MIRAGEN THERAPEUTICS, INC. (MGEN) has 10 open-market insider trades by 5 insiders since 2017. The most active filer is Kyle Lefkoff, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Logos Global Master Fund LP | 10% Owner | — | 1 | $4.3M | 2020-11-13 |
| Bruce Booth | Dir | — | 1 | $3.0M | 2018-02-13 |
| Kyle Lefkoff | Dir | — | 4 | $747K | 2017-03-10 |
| Thomas E. Hughes | Dir | — | 2 | $144K | 2018-10-11 |
| Adam Scott Levy | Chief Business Officer | — | 2 | $52K | 2018-02-13 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Logos Global Master Fund LP | 10% Owner | Buy | $4.3M | 2020-11-09 |
| Thomas E. Hughes | Director | Buy | $48K | 2018-10-11 |
| Bruce Booth | Director | Buy | $3.0M | 2018-02-13 |
| Adam Scott Levy | Chief Business Officer | Buy | $50K | 2018-02-13 |
| Thomas E. Hughes | Director | Sell | $96K | 2017-12-20 |
| Adam Scott Levy | Chief Business Officer | Buy | $2K |
Companies that share insiders with MGEN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2017-06-22 |
| Kyle Lefkoff | Director | Sell | $83K | 2017-03-09 |
| Kyle Lefkoff | Director | Sell | $378K | 2017-03-06 |
| Kyle Lefkoff | Director | Sell | $143K | 2017-02-24 |
| Kyle Lefkoff | Director | Sell | $142K | 2017-02-22 |